Publications by authors named "C Droz"

Claim this Profile
C
Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS.
Patrick Blin, Caroline Dureau-Pournin, Jacques Bénichou, Yves Cottin, Patrick Mismetti, Cécile Droz

Am J Cardiovasc Drugs· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015).
M Sabaté, X Vidal, E Ballarin, M Rottenkolber, S Schmiedl, C Droz

Front Pharmacol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Ibuprofen Worsen COVID-19?
Nicholas Moore, Bruce Carleton, Patrick Blin, Pauline Bosco-Levy, Cecile Droz

Drug Saf· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years.
Stéphane Ducassou, Anne Gourdonneau, Helder Fernandes, Guy Leverger, Marlène Pasquet, Cécile Droz

Br J Haematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary prevention of acute coronary syndrome with antiplatelet agents in real life: A high-dimensional propensity score matched cohort study in the French National claims database.
Patrick Blin, Caroline Dureau-Pournin, Jérémy Jové, Regis Lassalle, Cécile Droz

MethodsX· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis